Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
Finney, Olivia C.
Danziger, Samuel A.
Molina, Douglas M.
Vignali, Marissa
Takagi, Aki
Ji, Ming
Stanisic, Danielle I.
Siba, Peter M.
Liang, Xiawu
Aitchison, John D.
Mueller, Ivo
Gardner, Malcolm J.
Wang, Ruobing
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2014
Size
File type(s)
Location
License
Abstract

Malaria remains one of the most prevalent and lethal human infectious diseases worldwide. A comprehensive characterization of antibody responses to blood stage malaria is essential to support the development of future vaccines, sero-diagnostic tests, and sero-surveillance methods. We constructed a proteome array containing 4441 recombinant proteins expressed by the blood stages of the two most common human malaria parasites, P. falciparum (Pf) and P. vivax (Pv), and used this array to screen sera of Papua New Guinea children infected with Pf, Pv, or both (Pf/Pv) that were either symptomatic (febrile), or asymptomatic but had parasitemia detectable via microscopy or PCR. We hypothesized that asymptomatic children would develop antigen-specific antibody profiles associated with antidisease immunity, as compared with symptomatic children. The sera from these children recognized hundreds of the arrayed recombinant Pf and Pv proteins. In general, responses in asymptomatic children were highest in those with high parasitemia, suggesting that antibody levels are associated with parasite burden. In contrast, symptomatic children carried fewer antibodies than asymptomatic children with infections detectable by microscopy, particularly in Pv and Pf/Pv groups, suggesting that antibody production may be impaired during symptomatic infections. We used machine-learning algorithms to investigate the relationship between antibody responses and symptoms, and we identified antibody responses to sets of Plasmodium proteins that could predict clinical status of the donors. Several of these antibody responses were identified by multiple comparisons, including those against members of the serine enriched repeat antigen family and merozoite protein 4. Interestingly, both P. falciparum serine enriched repeat antigen-5 and merozoite protein 4 have been previously investigated for use in vaccines. This machine learning approach, never previously applied to proteome arrays, can be used to generate a list of potential seroprotective and/or diagnostic antigens candidates that can be further evaluated in longitudinal studies.

Journal Title

Molecular and Cellular Proteomics

Conference Title
Book Title
Edition
Volume

13

Issue

10

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© The American Society for Biochemistry and Molecular Biology. This research was originally published in Molecular & Cellular Proteomics (MCP). Finney et. al., Predicting anti-disease immunity using proteome arrays and sera from children naturally exposed to malaria Molecular & Cellular Proteomics (MCP), 13 (10) 2646-2660. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive version.

Item Access Status
Note
Access the data
Related item(s)
Subject

Medical parasitology

Persistent link to this record
Citation
Collections